Consensus Abbott Laboratories

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 12:14:02 2026-10-02 EDT			5-day change	1st Jan Change
96.56 ^USD	-0.13%		-4.42%	-22.73%

09:07am	Weak Jobs Lead to Stronger Stocks
07:47am	Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms	RE

Evolution of the Average Target: Abbott Laboratories

Evolution of the Target Price: Abbott Laboratories

Changes in Analyst Recommendations: Abbott Laboratories

06.ATkRnFHLbWVRj7kwP2ARlcl5mzkveUlAX4JViSaaKvk.Unt33xWgGAdh7eNvbj9mzYs73FJuESEvLMcy22j_UpNHfXb4FvlABwP38A~2155e5316ad86467a18332f0cc2c14c1

Analysts' recommendations: Abbott Laboratories

06:34am	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
05:39am	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
04:50am	Analyst recommendations: Airbnb, Hewlett Packard Enterprise, Fair Isaac, Nike…
08-21	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
08-13	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
08-13	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
07-28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
07-28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
07-23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
07-22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
07-17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
07-17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
07-17	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
07-17	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
07-17	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
07-17	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
07-17	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
07-16	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
07-06	Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120	MT
07-01	Baird Initiates Abbott Laboratories at Outperform With $121 Price Target	MT
06-12	BofA Adjusts Price Target on Abbott Laboratories to $102 From $120	MT
05-27	Goldman Sachs Adjusts Price Target on Abbott Laboratories to $113 From $121, Maintains Buy Rating	MT
05-05	Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase	MT
04-22	Analyst recommendations: Albemarle, Biogen, Qualcomm, Twilio, Lyondellbasell…
04-22	Daiwa Downgrades Abbott Laboratories to Neutral From Outperform, Adjusts PT to $92 From $113	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+24.38%
	MEDTRONIC PLC					+21.28%
	STRYKER CORPORATION					+34.74%
	ESSILORLUXOTTICA					+60.86%
	CENCORA, INC.					+19.2%
	HOYA CORPORATION					+23.82%
	BECTON, DICKINSON AND COMPANY					+9.88%
	IDEXX LABORATORIES, INC.					+35.46%
	DEXCOM, INC.					+10.26%
	ALCON INC.					+43.49%
	Average					+28.34%
	Weighted average by Cap.					+28.56%